Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Essential Hypertension

• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"
• A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
• A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
• NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
• Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
• A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
• A Prospective, Multicentre, Open-label, Single-arm Interventional Study of Bisoprolol (Nerkardou) (Between Low Dose and High Dose) 5 and 10 mg ODF Treatment In Egyptian Patients With Essential Hypertension
• A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
• A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
• Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
• A Study to Evaluate the Efficacy and Safety of AD-209
• A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers
• Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
• A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
• A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
• Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
• Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
• A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
• A Phase 3 Study to Evaluate and Compare the Efficacy and Safety of 8-week Treatment With AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects
• A Phase 3 Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
• Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
• Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.
• Study MIPAE - Melatonin and Essential Arterial Hypertension
• Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
• Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.
• Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI
• s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension
• A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
• Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
• Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
• A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community
• Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
• To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
• Management of Hypertension Utilizing Trained Community Health Worker in Rural Municipalities of Nepal
• Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
• Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary Intervention
• Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial
• Effect of Atorvastatin on Carotid Intima Media Thickness
• Repurposing Colchicine to Improve Vascular Function in Hypertension
• Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
• BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
• LCZ696 in Advanced LV Hypertrophy and HFpEF
• Efficacy of Chlorthalidone and Hydrochlorothiazide Combined With Amiloride on Blood Pressure in Primary Hypertension.
• A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
• Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
• The TARGET BP OFF-MED Trial
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
• A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension
• A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension
• Fimasartan in the Senior Subjects
• S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
• Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
• Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
• Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients
• An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
• Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
• Study of CS-3150 in Patients With Essential Hypertension
• Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension
• Safety Study of RMJH-111b to Treat Essential Hypertension
• Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients
• Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
• Canrenone as Add-on in Patients With Essential Hypertension
• Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension
• Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate
• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
• To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
• Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
• Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension
• Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension
• RAS Peptide Profiles in Patients With Arterial Hypertension
• The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy
• Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
• Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
• Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
• A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.
• BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy
• Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure
• A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
• Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension
• A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension
• Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
• Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
• Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension
• Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
• Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension
• Treatment of HYpertension: Morning Versus Evening
• Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension
• Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension
• A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
• A Study of LY2623091 in Participants With High Blood Pressure
• Micardis® in Patients With Essential Hypertension
• Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension
• Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension
• BIBR 277 Capsule in Patients With Essential Hypertension
• Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
• Fimasartan/Amlodipine Combination Phase III
• Microvascular Function in Primary Aldosteronism
• A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
• Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
• Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
• A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
• PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension
• Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
• Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension
• Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
• The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension
• Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study
• Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects
• Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo
• A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
• Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With St
• Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
• Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
• Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
• Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
• Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
• Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
• Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
• Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension
• Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension
• HaemoDYNAMICs in Primary and Secondary Hypertension
• The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension
• A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
• Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
• Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine
• Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension
• GRK4 Polymorphisms Blood Pressure Response to Candesartan
• Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension
• Perindopril Amlodipine for the Treatment of Hypertension
• Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
• Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension
• Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
• A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
• Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension
• Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting
• LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
• High Dose BAYA1040 CR: a Long Term Extension Study
• Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed
• The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
• Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations
• MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)
• A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
• Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
• MK-0954E Study in Participants With Hypertension (MK-0954E-357)
• MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)
• High Dose BAYA1040_Nifedipine: a Long Term Combination Study
• Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
• Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
• Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
• High Dose BAYA1040_Nifedipine: a Dose-comparative Study
• Essential Hypertension
• A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
• A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
• A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
• A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy
• Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
• Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
• Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions
• Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension
• The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables
• Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension
• Intensive Vasodilator Therapy in Patients With Essential Hypertension
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
• The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
• The Confirmatory Olmesartan Plaque Regression Study
• Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension
• Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion
• Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
• Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine
• Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
• Resistant Arterial Hypertension Cohort Study
• Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
• Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions
• Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions
• Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients
• Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
• Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
• Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
• A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers
• A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
• Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
• Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
• Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
• Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
• A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
• A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers
• A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
• Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
• Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
• Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
• A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers
• Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
• A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
• Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
• Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension
• Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)
• Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
• Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
• Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension
• Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
• Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
• A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
• China Stroke Primary Prevention Trial
• A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension
• Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension
• Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension
• Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
• A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
• Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly
• Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
• Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
• Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients
• Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study
• Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
• An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.
• A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
• One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
• Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg
• A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension
• To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
• Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular
• Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.
• Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension
• A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension
• Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
• Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
• Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension
• Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
• BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)
• Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
• Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
• Nijmegen Antihypertensive Management Improvement Study
• Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
• An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essent
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
• A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension
• Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
• Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
• Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
• Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study
• Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
• Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
• Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
• A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)
• Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
• Uric Acid in Essential Hypertension in Children
• Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension
• Olmesartan as an add-on to Amlodipine in Hypertension
• Amlodipine as add-on to Olmesartan in Hypertension
• Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
• Olmesartan Medoxomil in Atherosclerosis
• Olmesartan in Essential Hypertension
• A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension
• Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
• Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
• Olmesartan Medoxomil in Hypertension and Renal Impairment
• The Renin-Angiotensin System in Essential Hypertension
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
• Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension
• L-Arginine Metabolism in Essential Hypertension
• Diuretics In the Management of Essential Hypertension (DIME) Study
• Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
• Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)